India Moves To Make HIV/AIDS Drugs More Available
This article was originally published in PharmAsia News
India is the third-largest country for HIV-positive cases, yet its policy of free drugs to HIV/AIDS patients is not being fulfilled because of the vast distances patients have to travel. Many patients give up treatment because of the distances between places where the drugs are available and the cost of getting to them, even though the country has 147 centers for providing antiretroviral therapy. Some patients have to travel long, arduous distances three times a month for treatment. As a result, the Indian government is looking at "link centers" to bring treatment closer to the patients who need it. (Click here for more
You may also be interested in...
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.
Market Brief: Tissue-Engineered Wound Care Market Expected To Reach $1.9BN By 2024 Amid Rising Chronic Disease
The skin replacement market is led by three key players who have all been impacted by COVID-19, but the sector may see a quicker rebound than others as treatments cannot be deferred for a long time.